| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:1716.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Neurology Department (I.C., C.T., F.W., M.-G.B.) and Angio-Haematology Department (C.S., L.D.), Lariboisière Hospital; Inserm U708 (C.T.); and the Emergency Headache Center (A.D.), Lariboisière Hospital, Paris, France.
Correspondence to Isabelle Crassard, Neurology Department, Lariboisière Hospital, 2 rue Ambroise Paré, 75010 Paris, France. E-mail: isabelle.crassard{at}lrb.aphp.fr
Background and Purpose Cerebral venous thrombosis (CVT) is an infrequent variety of cerebrovascular disease with a wide spectrum of clinical presentations and a notoriously difficult diagnosis. Previous reports have emphasized the potential clinical utility of D-dimer assay in CVT diagnosis.
Methods A rapid sensitive D-dimer assay was performed at entry in 73 patients with CVT <30 days duration, examined in our institution between 1999 and 2003.
Results The mean value of D-dimer levels was 1521 ng/mL; 7 patients (10% of all patients and 26% of those presenting with isolated headache) had values <500 ng/mL. In a multivariate analysis, isolated headache was the only variable associated with a negative D-dimer assay.
Conclusion A negative D-Dimer assay does not confidently rule out CVT, particularly in the setting of recent isolated headache.
Key Words: cerebral thrombosis headache sinus thrombosis
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |